Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Date of authorisation: 19/11/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 11, Status: Authorised

Minutes of the COMP meeting 4-6 November 2025

3-year rolling work plan for the Quality Innovation Group (QIG) 2026-2028

Medicine evaluation figures

Human medicines European public assessment report (EPAR): Ebglyss, lebrikizumab, Date of authorisation: 16/11/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 25, Status: Authorised

Human medicines in 2025

Classification of changes: questions and answers